Lesson
Iodide Capture and Thyroid Hormone Biosynthesis
Thyroid hormone chemistry begins when an inorganic ion is concentrated, oxidized, attached to tyrosyl residues, and coupled within a large protein scaffold.
- Sodium iodide symporter
- Pendrin
- Thyroid peroxidase
- Organification
- MIT and DIT coupling
NIS concentrates iodide and apical transport delivers it to the lumen
Oxidized iodine forms MIT and DIT on tyrosyl residues
MIT plus DIT forms T3 while DIT plus DIT forms T4
Concentrate and move iodide
The sodium iodide symporter uses the sodium gradient to concentrate iodide at the basolateral membrane. Iodide then reaches the follicular lumen through apical transport that includes pendrin. Perchlorate and related anions can compete at the uptake step.
Create reactive iodine
Thyroid peroxidase uses hydrogen peroxide to oxidize iodide and attach iodine to tyrosyl residues within thyroglobulin. One iodine produces monoiodotyrosine, or MIT, while two produce diiodotyrosine, or DIT.
Couple inside thyroglobulin
Coupling two DIT residues forms a T4 residue. Coupling one MIT with one DIT forms a T3 residue. The hormones remain part of thyroglobulin until proteolysis releases them, while unused MIT and DIT are deiodinated so iodide can be recycled.
Quick check
Lesson
The Thyronine Scaffold
T4 and T3 are iodinated amino-acid derivatives built around two aromatic rings joined by an ether, with iodine placement controlling mass, conformation, metabolism, and receptor fit.
- Diphenyl ether
- Alpha-amino acid
- Phenolic hydroxyl
- Iodine pattern
- T4 versus T3
A chiral alpha carbon carries amino and carboxyl groups
An oxygen atom joins the inner and outer aromatic rings
Position and count distinguish T4, T3, and inactive metabolites
Recognize the common framework
The thyronine core contains two aromatic rings connected by an oxygen atom. One ring carries an alanine-like amino-acid side chain, and the other carries a phenolic hydroxyl group. This scaffold is much larger and more lipophilic than an unmodified amino acid.
Count iodine with purpose
T4 contains four iodine atoms and T3 contains three. Removing the outer-ring 5-prime iodine from T4 produces T3, which binds thyroid hormone receptors more avidly. Removing an inner-ring iodine instead produces an inactive or less active metabolite.
Connect structure to handling
The amino and carboxyl groups allow salt formation and transporter recognition. The phenolic group participates in conjugation, while the heavy iodine substituents strongly influence protein binding, distribution, and the chemistry of deiodination.
Quick check
Lesson
Stereochemistry, Transport, and Receptor Recognition
The spatial arrangement of the amino-acid center and the orientation of the iodinated rings determine whether a thyronine analog is transported, metabolized, and recognized as a physiologic signal.
- L configuration
- Chirality
- Transport proteins
- TR alpha and TR beta
- Nuclear transcription
The chiral center places the side chain for biologic recognition
Membrane transporters help determine tissue hormone exposure
T3 stabilizes receptor complexes that control transcription
Preserve the physiologic configuration
Levothyroxine and liothyronine are the L forms of T4 and T3. The chiral center fixes the side chain in a receptor-compatible spatial arrangement. A mirror-image form can have substantially different biologic activity even though elemental composition is unchanged.
Cross membranes through transport systems
Thyroid hormones are not explained by passive lipid diffusion alone. Transporters such as MCT8 help move hormone into cells, and transporter defects can create tissue-specific patterns that circulating concentrations do not fully predict.
Convert binding into transcription
T3 is the higher-affinity ligand for thyroid hormone receptor alpha and beta isoforms. Receptor complexes bind DNA response elements and recruit coregulators, so receptor isoform, tissue distribution, local T3 supply, and chromatin context shape the response.
Quick check
Lesson
Deiodination and Metabolic Direction
Deiodinases do more than remove iodine. They choose a ring, and that positional choice directs T4 toward active T3 or toward inactive reverse T3 and downstream metabolites.
- DIO1
- DIO2
- DIO3
- Outer-ring activation
- Inner-ring inactivation
T4 becomes receptor-active T3
Selected tissues create intracellular T3 near its receptor
T4 becomes reverse T3 and T3 can become T2
Activate through the outer ring
DIO1 and DIO2 can remove an outer-ring iodine from T4 to form T3. DIO2 is especially important for local intracellular T3 supply in selected tissues, allowing a tissue to regulate receptor exposure partly independently of serum T3.
Inactivate through the inner ring
DIO3 removes an inner-ring iodine from T4 to form reverse T3 and can convert T3 to T2. This pathway lowers active hormone signaling and becomes especially important in development and selected illness states.
Recognize a selenium-dependent reaction
Deiodinases are selenoproteins that use a reactive selenocysteine at the catalytic site. Drug effects, illness, nutrition, and tissue expression can shift conversion, but laboratory findings must still be interpreted in clinical context.
Quick check
Lesson
Levothyroxine and Liothyronine as Replacement Analogs
One iodine atom separates T4 from T3, yet that change produces major differences in receptor potency, half-life, concentration peaks, dosing behavior, and clinical risk.
- Levothyroxine
- Liothyronine
- Sodium salts
- Protein binding
- Exposure profile
Long persistence and tissue conversion support stable replacement
Direct receptor-active hormone acts faster and clears sooner
Pharmaceutical salt forms support handling and dissolution
Use T4 as a circulating reservoir
Levothyroxine supplies the tetraiodinated prohormone. Strong plasma-protein binding and gradual tissue conversion support a long, buffered exposure profile and make TSH-based titration practical in primary hypothyroidism.
Understand direct T3 exposure
Liothyronine supplies the triiodinated receptor-active hormone. It acts faster and has a shorter biologic half-life, so oral dosing can create higher peaks and larger fluctuations with greater concern for cardiac and skeletal effects.
Distinguish active moiety from salt
Commercial products commonly use sodium salts to support pharmaceutical handling and dissolution. The salt name describes the dosage-form ingredient, while levothyroxine or liothyronine is the pharmacologically active hormone moiety after dissolution.
Quick check
Lesson
Thionamide Scaffolds and Enzyme Inhibition
Methimazole and propylthiouracil share a sulfur-rich antithyroid function but use different heterocyclic scaffolds and differ in potency, duration, peripheral conversion effects, and toxicity.
- Methimazole imidazole
- PTU thiouracil
- Sulfur pharmacophore
- TPO inhibition
- DIO1 inhibition
A compact mercaptoimidazole scaffold blocks TPO-dependent chemistry
A propyl-substituted pyrimidinethione also blocks synthesis
PTU additionally inhibits type 1 conversion of T4 to T3
Contrast the ring systems
Methimazole is a methyl-substituted mercaptoimidazole. Propylthiouracil is a propyl-substituted thiouracil related to a pyrimidinone scaffold. Both present sulfur-containing functionality that interferes with TPO-dependent thyroid hormone synthesis.
Block new synthesis
Thionamides inhibit TPO-catalyzed oxidation, organification, and coupling. They do not remove hormone already stored in thyroglobulin, which explains the delayed clinical response and their poor fit for destructive thyroiditis.
Identify the PTU distinction
PTU also inhibits peripheral type 1 deiodination of T4 to T3. This additional action can matter in thyroid storm, but it does not erase the serious hepatic risk that limits routine PTU use.
Quick check
Lesson
Iodide, Pharmacologic Iodine, and Radioiodine
The same element can serve as nutrient substrate, a high-dose inhibitor of hormone release, a diagnostic tracer, or a tissue-directed radiation source depending on isotope, dose, timing, and chemical form.
- Stable iodide
- Acute iodine effect
- Iodine-123
- Iodine-131
- Thyroid selectivity
Nutrient substrate enters hormone synthesis
Short-lived photon emission supports diagnostic imaging
Beta emission damages iodine-concentrating thyroid tissue
Separate substrate from high-dose effect
Physiologic iodide supplies hormone synthesis. A large acute iodide exposure can transiently inhibit organification and hormone release, but escape from this effect can occur, so timing and disease context matter.
Use uptake as a targeting mechanism
Thyroid follicular cells concentrate radioiodide through the same transport system used for stable iodide. This creates tissue selectivity, while recent iodine exposure or competing anions can reduce uptake and alter a scan or treatment.
Match isotope to purpose
I-123 is commonly favored for diagnostic uptake and imaging because of its photon emissions and short physical half-life. I-131 emits beta particles that damage nearby tissue and gamma photons that permit detection, making it useful for ablation and treatment under strict radiation and reproductive safeguards.
Quick check
Lesson
Formulation, Stability, and Absorption
A microgram-dose hormone with a narrow therapeutic index can become clinically unstable when formulation, dissolution, gastrointestinal chemistry, binding agents, storage, or product switching changes exposure.
- Microgram potency
- Dissolution
- Chelation and adsorption
- pH and gastric conditions
- Product consistency
Moisture, heat, light, and product quality can alter delivered dose
Dosage form and gastrointestinal conditions shape availability
Calcium, iron, binders, food, and feeds can reduce absorption
Respect small absolute changes
Levothyroxine is dosed in micrograms, so modest formulation or administration changes can represent a meaningful fraction of the daily dose. Product potency, content uniformity, moisture, heat, and light protection therefore matter.
Identify physical interactions
Calcium, iron, aluminum products, bile acid sequestrants, phosphate binders, and selected resins can complex with or adsorb levothyroxine in the gut. Food, enteral nutrition, and altered gastric conditions can also change dissolution and absorption.
Treat switching as a new exposure
Tablets, soft-gel capsules, liquids, and intravenous products differ in excipients and delivery behavior. A manufacturer or formulation switch can be reasonable, but consistent use and planned laboratory reassessment preserve interpretability.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.
- NIH PubChem levothyroxine record
- NIH PubChem liothyronine record
- NIH PubChem methimazole record
- NIH PubChem propylthiouracil record
- NCBI Endotext thyroid hormone synthesis
- IUPHAR thyroid hormone receptor family
- Current Synthroid prescribing information
- Current Cytomel prescribing information
- Current methimazole prescribing information
- Current propylthiouracil prescribing information